|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 315,30 CHF | -0,76% |
|
+0,64% | +23,41% |
| 07:38 | Roche lanceert nieuwe PCR-test voor vaginitis na verkrijgen CE-markering | MT |
| 07:15 | Roche ontvangt EU-goedkeuring voor behandeling van actieve lupusnefritis | MT |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | k/w-verhouding (N) | Koers-boekwaarde (N) | PEG (N) | EV/omzet (N) | Beurskap. / EBITDA (N) | Beurskap. / EBIT (N) | Dividendrendement (N) | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|
 | 18.44x | 6.58x | 0.27x | 4.63x | 11.59x | 13.15x | 3,11% | 336 mld. | |
| 43.61x | 32.84x | 0.46x | 14.44x | 32.05x | 34.43x | 0,59% | 893 mld. | |
| 19.24x | 6.18x | 0.24x | 5.4x | 14.95x | 16.4x | 2,56% | 486 mld. | |
| 52.12x | -538.68x | 0.66x | 7.39x | 17.51x | 18.01x | 2,92% | 394 mld. | |
| 27.22x | 6.14x | 0.57x | 5.16x | 15.3x | 16.09x | 1,78% | 280 mld. | |
| 18.22x | 5.71x | 0.81x | 4.93x | 11.59x | 12.49x | 3,1% | 253 mld. | |
| 12.78x | 4.56x | 0.86x | 4.18x | 8.94x | 10.09x | 3,27% | 246 mld. | |
| 12.97x | 7.04x | 6.79x | 4.66x | 9.64x | 11.15x | 3,89% | 207 mld. | |
| 24.54x | 19.41x | 0.34x | 5.99x | 10.29x | 13.75x | 2,97% | 173 mld. | |
| 17.68x | 6.63x | 0.01x | 5.58x | 10.21x | 12.27x | 2,73% | 150 mld. | |
| 13.34x | 1.62x | 0.36x | 2.99x | 7.53x | 8.67x | 6,62% | 147 mld. | |
| 12.16x | 1.3x | 0.24x | 2.62x | 8.52x | 9.49x | 4,97% | 118 mld. | |
| 28.46x | 6.01x | -0.03x | 8.6x | 18.57x | 19.29x | -.--% | 112 mld. | |
| 12.21x | 5.31x | -0.06x | 2.89x | 8.39x | 8.75x | 4,78% | 105 mld. | |
| 13.14x | 5.1x | 0.11x | 2.69x | 7.93x | 9.09x | 3,57% | 97,31 mld. | |
| 31.58x | 6.87x | 2.97x | 10.18x | 19.92x | 21.3x | 3,09% | 86,79 mld. | |
| 188.11x | 67.93x | -0.92x | 14.75x | 97.37x | 94.25x | -.--% | 56,81 mld. | |
| 47.09x | 6.89x | 1.44x | 11.37x | 37.37x | 39.3x | 0,44% | 58,65 mld. | |
| 40.05x | 1.02x | 0.64x | 2.44x | 9.01x | 25.91x | 4,49% | 45,17 mld. | |
| Gemiddelde | 33,31x | -17,98x | 0,83x | 6,36x | 18,77x | 20,73x | 2,89% | 223,44 mld. | |
| Gewogen gemiddelde per kap. | 29,95x | -37,86x | 0,78x | 7,38x | 18,17x | 19,78x | 2,52% |
- Beurs
- Aandelen
- Koers ROG
- Sector Roche Holding AG
- Sectorale waarderingen
Kies jouw editie
Alle financiële informatie op nationaal niveau
